These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17135335)

  • 1. Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract.
    Cantor LB; Hoop J; Wudunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
    Br J Ophthalmol; 2007 May; 91(5):629-32. PubMed ID: 17135335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the free acid of bimatoprost in aqueous humor samples from human eyes treated with bimatoprost before cataract surgery.
    Camras CB; Toris CB; Sjoquist B; Milleson M; Thorngren JO; Hejkal TW; Patel N; Barnett EM; Smolyak R; Hasan SF; Hellman C; Meza JL; Wax MB; Stjernschantz J
    Ophthalmology; 2004 Dec; 111(12):2193-8. PubMed ID: 15582073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous humor concentrations of bimatoprost free acid, bimatoprost and travoprost free acid in cataract surgical patients administered multiple topical ocular doses of LUMIGAN or TRAVATAN.
    Faulkner R; Sharif NA; Orr S; Sall K; Dubiner H; Whitson JT; Moster M; Craven ER; Curtis M; Pailliotet C; Martens K; Dahlin D
    J Ocul Pharmacol Ther; 2010 Apr; 26(2):147-56. PubMed ID: 20307216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human ocular distribution of bimatoprost and latanoprost.
    Ichhpujani P; Katz LJ; Hollo G; Shields CL; Shields JA; Marr B; Eagle R; Alvim H; Wizov SS; Acheampong A; Chen J; Wheeler LA
    J Ocul Pharmacol Ther; 2012 Apr; 28(2):134-45. PubMed ID: 22136089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice.
    Crowston JG; Lindsey JD; Morris CA; Wheeler L; Medeiros FA; Weinreb RN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4571-7. PubMed ID: 16303950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 24-Hour IOP control with once-daily bimatoprost, timolol gel-forming solution, or latanoprost: a 1-month, randomized, comparative clinical trial.
    Walters TR; DuBiner HB; Carpenter SP; Khan B; VanDenburgh AM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S26-35. PubMed ID: 15016559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latanoprost 0.005% versus bimatoprost 0.03% in primary open-angle glaucoma patients.
    Konstas AG; Katsimbris JM; Lallos N; Boukaras GP; Jenkins JN; Stewart WC
    Ophthalmology; 2005 Feb; 112(2):262-6. PubMed ID: 15691561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of bimatoprost and a fixed combination of latanoprost and timolol on circadian intraocular pressure.
    Rossetti L; Karabatsas CH; Topouzis F; Vetrugno M; Centofanti M; Boehm A; Viswanathan A; Vorwerk C; Goldblum D
    Ophthalmology; 2007 Dec; 114(12):2244-51. PubMed ID: 17459480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
    Yildirim N; Sahin A; Gultekin S
    J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of ocular hypotensive action of bimatoprost (Lumigan) in patients with ocular hypertension or glaucoma.
    Christiansen GA; Nau CB; McLaren JW; Johnson DH
    Ophthalmology; 2004 Sep; 111(9):1658-62. PubMed ID: 15350319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, investigator-masked comparison of diurnal responder rates with bimatoprost and latanoprost in the lowering of intraocular pressure.
    Choplin N; Bernstein P; Batoosingh AL; Whitcup SM;
    Surv Ophthalmol; 2004 Mar; 49 Suppl 1():S19-25. PubMed ID: 15016558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
    Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
    Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC; Konstas AG; Nelson LA; Kruft B
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of long-term intraocular pressure fluctuation in patients treated with bimatoprost or latanoprost.
    Simmons ST; Bernstein P; Hollander DA
    Am J Ophthalmol; 2008 Sep; 146(3):473-7. PubMed ID: 18561893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility and efficacy of a mass switch from latanoprost to bimatoprost in glaucoma patients in a prepaid Health Maintenance Organization.
    Law SK; Song BJ; Fang E; Caprioli J
    Ophthalmology; 2005 Dec; 112(12):2123-30. PubMed ID: 16225924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised crossover study comparing bimatoprost and latanoprost in subjects with primary angle closure glaucoma.
    How AC; Kumar RS; Chen YM; Su DH; Gao H; Oen FT; Ho CL; Seah SK; Aung T
    Br J Ophthalmol; 2009 Jun; 93(6):782-6. PubMed ID: 19336424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of prostaglandin analogues on the blood aqueous barrier and corneal thickness of phakic patients with primary open-angle glaucoma and ocular hypertension.
    Arcieri ES; Pierre Filho PT; Wakamatsu TH; Costa VP
    Eye (Lond); 2008 Feb; 22(2):179-83. PubMed ID: 16936646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of latanoprost, travoprost, and bimatoprost on circadian intraocular pressure in patients with glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Bottoli A; Fogagnolo P
    Ophthalmology; 2006 Feb; 113(2):239-46. PubMed ID: 16458092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension.
    Hepsen IF; Ozkaya E
    Eye (Lond); 2007 Apr; 21(4):453-8. PubMed ID: 16543930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro study of inflammatory potential and toxicity profile of latanoprost, travoprost, and bimatoprost in conjunctiva-derived epithelial cells.
    Guenoun JM; Baudouin C; Rat P; Pauly A; Warnet JM; Brignole-Baudouin F
    Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2444-50. PubMed ID: 15980234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.